HTLV AWARE
  • Home
  • Global strategy
  • Australia Forum Update
  • Meet our reps
  • Meet the experts
  • What is HTLV?
  • HTLV-1
  • HTLV-2
  • Diagnosis
  • HTLV diseases
    • Asymptomatics
    • HAM/TSP
    • ATLL
    • Other Diseases
  • Treatment
    • Asymptomatics
    • HAM/TSP
    • ATLL
    • Science >
      • History & More info
      • Ongoing trials
  • Global
    • United Kingdom
    • United States
    • Brazil
    • Argentina
  • Contact Us
    • Further Info
    • News & Events
    • HTLV Resources
  • Blog
    • Your Journey
Our community is supported by HTLV specialists & research from across the globe

Meet the experts

Professor Charles Bangham
HTLV 
specialist
​London, UK

Since 1987 I have studied the virology and immunology of persistent virus infections, in particular infection with the human T-cell leukaemia virus (HTLV-I).

Our aim is to produce a comprehensive, coherent, qualitative and quantitative understanding of the persistence of HTLV-I and the immune response to HTLV-I, and an explanation of why certain individuals infected with HTLV-I develop fatal or disabling diseases while the majority remain asymptomatic. We use a broad range of techniques in molecular and cellular immunology, viral and host genetics, cell biology, DNA expression microarrays, proteomics and mathematics.

Powered by Create your own unique website with customizable templates.
  • Home
  • Global strategy
  • Australia Forum Update
  • Meet our reps
  • Meet the experts
  • What is HTLV?
  • HTLV-1
  • HTLV-2
  • Diagnosis
  • HTLV diseases
    • Asymptomatics
    • HAM/TSP
    • ATLL
    • Other Diseases
  • Treatment
    • Asymptomatics
    • HAM/TSP
    • ATLL
    • Science >
      • History & More info
      • Ongoing trials
  • Global
    • United Kingdom
    • United States
    • Brazil
    • Argentina
  • Contact Us
    • Further Info
    • News & Events
    • HTLV Resources
  • Blog
    • Your Journey